Bone marrow aspirate concentrate (BMAC):
Contains mesenchymal stem cells and growth factors derived from bone marrow. Used for similar indications as PRP. Evidence is more limited
Platelet-rich plasma (PRP) and other biologic injections represent a growing area of interest in the nonsurgical management of joint arthritis. These treatments use the body’s own healing factors to promote a biological response within the joint, potentially reducing pain and inflammation through mechanisms different from cortisone or hyaluronic acid.

Dr. Leo Zalikha offers PRP and select biologic injection options for appropriate patients. He is transparent about what the current evidence supports, what remains uncertain, and what patients can realistically expect.
PRP stands for platelet-rich plasma. Platelets are blood cells that contain growth factors involved in tissue healing and repair. PRP is created by drawing a small amount of your blood, processing it in a centrifuge to concentrate the platelets, and injecting that concentrated solution into the affected joint.
The theory is that delivering a high concentration of growth factors directly to the arthritic joint promotes anti-inflammatory effects and may slow or modify the disease process. PRP has been studied for knee osteoarthritis more than any other joint application.
The entire process takes about 30 to 45 minutes in the office.
PRP for knee osteoarthritis has been studied in multiple randomized controlled trials and meta-analyses. The findings are generally encouraging but not uniformly conclusive:
Dr. Zalikha is honest about these nuances. PRP is a reasonable option for some patients, but it is not a miracle treatment, and expectations should be calibrated to the evidence.
Further reading: Does PRP really work for knee pain?
PRP is most appropriate for:
PRP is less likely to be effective for:
Beyond PRP, several other biologic and regenerative injection products are available or under investigation:
Contains mesenchymal stem cells and growth factors derived from bone marrow. Used for similar indications as PRP. Evidence is more limited
Derived from donated amniotic membrane. Marketed for anti-inflammatory and regenerative properties. Evidence for arthritic joints is early-stage
Concentrated anti-inflammatory proteins from the patient's own blood.
Dr. Zalikha evaluates emerging biologic options as the evidence develops. He does not offer treatments that lack a reasonable evidence base or that make promises unsupported by data. When a newer option shows genuine promise, he incorporates it into his practice and discusses the current state of the evidence with patients openly.
PRP injections are typically not covered by insurance, including Medicare and most commercial plans. The out-of-pocket cost varies by preparation type and is discussed during your consultation.
Other biologic injections may also be self-pay. Dr. Zalikha’s office provides clear pricing information before treatment so there are no surprises.